SDC1 and neoplasm: However, although it seems likely that aberrant expression of syndecan-1 favors tumor progression, analysis of 51/55 patients in the survival study group revealed lack of significance between stromal syndecan-1 expression and survival (log rank test: p = 0.2765; Fig. 1b).